Loading...
•
Dec 31, 2021
Rxsight Q4 2021 Earnings Report
RxSight, Inc. reported financial results, showcasing revenue growth driven by increased sales of LDDs and LALs.
Key Takeaways
RxSight, Inc. reported a 71% increase in revenue for the fourth quarter of 2021, reaching $8.4 million, driven by growth in LDD and LAL sales. The company's gross profit increased to $2.9 million, but it experienced a net loss of $15.7 million due to increased operating expenses.
Achieved fourth quarter revenue of $8.4 million, a 71% increase year-over-year.
Sold 45 Light Delivery Devices (LDDs), expanding the installed base to 206.
Sold 2,959 Light Adjustable Lenses (LALs).
Gross profit for the fourth quarter of 2021 was $2.9 million, or 34% of revenue, compared to $1.4 million, or 28% for the fourth quarter of 2020.
Forward Guidance
RxSight projects 2022 full year revenue to be between $40.0 million and $44.0 million, full year gross margin of 35% to 36% of revenue and full year operating expenses of $86.0 million to $90.0 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...